Tyler Palmer

Equibles does not estimate personal net worth.

Get an email with a short summary when Sanara MedTech Inc. publishes a filing, an earnings call transcript or a press release.

Get SMTI alerts

About Tyler Palmer

Sanara MedTech Inc. reported in an 8-K filed April 5, 2024 that Tyler Palmer was appointed Chief Corporate Development and Strategy Officer, effective April 1, 2024. Sanara MedTech Inc. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Sanara MedTech Inc. includes Ronald T. Nixon (CEO), Seth D. Yon (CEO and Board Member), Seth Yon (CEO and Board Member) and 7 others.

“Mr. Waldrop's appointment is effective April 15, 2024 and Mr. Palmer's appointment was effective April 1, 2024.”

Sanara MedTech Inc. Form 8-K, filed April 5, 2024 · Read the filing

Affiliation history

Sanara MedTech Inc. (SMTI)
SEC 8-K

Current
2024-04-01–present

Company network

Sanara MedTech Inc.

SMTI

Current role

Medical Instruments & Supplies · Healthcare

Leadership on record at Sanara MedTech Inc.

Ronald T. Nixon CEO
Seth D. Yon CEO, Board Member
Seth Yon CEO, Board Member
Suresh V. Muppalla CEO
J. Michael Carmena Chairman
Elizabeth B. Taylor CFO
Elizabeth Taylor CFO
Michael D CFO
Michael McNeil CFO, Chief Accounting Officer
Jacob A. Waldrop COO

Recent activity

Executive change Appointed: Chief Corporate Development and Strategy Officer Sanara MedTech Inc. (SMTI)
2024-04-01